A study was carried out to examine the independence from starting prebronchodilator FEV1 of four indices commonly used to express airflow (FEV,) reversibility in response to bronchodilators. In 121 patients with chronic airflow obstruction with a mean prebron- chodilator circumstances be a more appropriate index of reversibility.4 This conclusion, however, was based on the results of a single test of response to an anticholinergic agent in a well defined homogeneous group of patients. We have examined the relation of this index and three other commonly used indices of reversibility in response to the prebronchodilator FEV, in a heterogeneous group of patients with chronic airflow obstruction, measuring the response to both an anticholinergic agent, ipratropium bromide, and a /2 agonist, salbutamol.
FEV, was the least dependent on starting FEV,. Reversibility circumstances be a more appropriate index of reversibility.4 This conclusion, however, was based on the results of a single test of response to an anticholinergic agent in a well defined homogeneous group of patients. We have examined the relation of this index and three other commonly used indices of reversibility in response to the prebronchodilator FEV, in a heterogeneous group of patients with chronic airflow obstruction, measuring the response to both an anticholinergic agent, ipratropium bromide, and a /2 agonist, salbutamol.
Methods
One hundred and twenty one outpatients, with a diagnosis of non-asthmatic chronic airflow obstruction and an FEV, below 70% predicted, completed a trial to assess corticosteroid responsiveness.5 Reversibility of the FEV, in response to 500 pg ipratropium bromide and 10 mg salbutamol was measured on different days during the 14 day run in period, before any corticosteroid was administered. Patients were asked to refrain from inhaled bronchodilators for six hours and oral bronchodilators for 24 hours before the laboratory visit. Each drug was given diluted in 2 ml normal saline via an Inspiron Minineb driven by the same air compressor to dryness. FEV, was measured on a dry wedge spirometer (Vitalograph) before the drug was inhaled and 20 minutes (salbutamol) or 25 minutes (ipratropium) after nebulisation had finished. The mean of three technically satisfactory attempts within 10% or 100 ml (whichever was the smaller) was used for subsequent analysis.
Reversibility of FEV, was expressed in four ways, as shown below:
1 as absolute change (ml) from the prebronchodilator value (absolute):
postbronchodilator FEV, -prebronchodilator FEV, ( The choice of which index of reversibility should be used in a particular study will depend on the reason for investigating reversibility. Intuitively, an index free of dependence on another variable under study may seem generally most appropriate. If, however, the use of an FEV, dependent variable gives additional useful information about the question under study-say, decline in lung function or treatment response-then the use of that variable will be justified. In all cases, however, the data on reversibility generated by a study should be examined for dependence on prebroncho- 
